Emmy Betz, MD, MPH, professor of emergency medicine, and colleagues have been awarded a $1.7 million National Institutes of Health grant for a national study designed to improve firearm safety for people with Alzheimer’s disease and related dementias.
People who get COVID-19 have a treatment option that can significantly reduce their odds of hospitalization, but it’s not a substitute for trying to avoid infection in the first place through vaccination, doctors say.
Dr. Bebarta was awarded a highly competitive NIH R21 research grant to study the use of thiosulfate for chlorine gas exposures, which can cause deadly respiratory symptoms in military or industrial exposures.
Recent work by Dr. Ginde and colleagues from the CDC's IVY Network demonstrates the sustained effectiveness of mRNA vaccines against severe outcomes from COVID-19, including hospitalization. The data, which includes some time in which the Delta variant was dominant, were featured in a White House press conference with Surgeon General Murthy, CDC Director Walensky, and White House Health Advisor Fauci.
Dr. Ginde's Early Critical Care Trials Group was a core contributor to research recently published in the Journal Clinical Infectious Diseases demonstrating the effectiveness of COVID vaccines in the early phases of the pandemic.
JAMA recently featured a review of US gun violence research – explaining that the 1996 Dickey Amendment dramatically chilled funding for research, even as gun deaths steadily increased. The same article highlighted Dr. Emmy Betz’s role thawing that chill. As a recognized leader in federally-supported gun violence research, Dr. Betz, her team and the Department of Emergency Medicine are developing solutions to reverse the increase in gun-related violence.
With all the proposed COVID therapies being talked about, monoclonal antibody treatment has received little attention, compared to its strong effectiveness in preventing serious disease and hospitalization. Dr. Adit Ginde is leading a team to improve uptake of this important therapy. His work is starting to catch on in statewide media.
Vitamin D is being studied as an essential factor in many diseases, including respiratory infections and COVID-19. The evidence is complex, and conclusions are difficult to draw. Dr. Ginde helps sort out the confusion in this NPR story.
Enacting firearm-related legislation alone won’t solve the problem of firearm-related injuries and deaths — nor will education, nor will engineering. We need them all — and we need the research to inform them all. We need to engage varied voices in these discussions. We need to move away from vilifying the “other side” and instead embrace the fact that all of us want to keep our friends and loved ones safe from harm.
A new $8.7 million grant from the National Institutes of Health (NIH) will fuel a statewide project to improve care of patients affected by COVID-19. Adit Ginde, MD, MPH, Professor of Emergency Medicine is leading a team of researchers from the Colorado Clinical and Translational Sciences Institute at the University of Colorado Anschutz Medical Campus to test the real-world effectiveness of monoclonal antibody treatment for high-risk COVID-19 outpatients.